paperKB
coga / coga-kb
Help
Sign in

Chunk #19 — Discussion

Source
Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval.
Embedded
yes

Text

success rates as a whole [25]. However, we still find a large positive effect of OMIM genetic evidence when we exclude hereditary diseases and MeSH terms mapped to OMIM phenotypes from the analysis (S21 Table, S27 Fig). We conclude the predictive effect of OMIM genetic evidence is not a statistical artifact, and is more likely to reflect the value of well-defined disease biology to drug development.